Table 1 Detailed demographic and clinical summary of cases with postvitrectomy endophthalmitis
Case | Sex/Age/Eye | Medical history | Indication of vitrectomy | Type of surgery (gauge) | IOL placement/ Endotamponade used | Causative organisms | Intravitreal agents (number of injections) | Systemic treatment | Rescue PPV | Complications | Presenting BCVA (Log MAR) | Final BCVA (Log MAR) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F/74/R | None | EMM | 20 | N/Fluid | ND | VC (1), CT (1) | Levofloxacin | Y | None | 2.60 | 0.20 |
2 | F/49/R | DM | Diabetic TRD | 20 | N/Air | MRSA | VC (1), CT (1) | Ciprofloxacin | N | RRD | 2.60 | 2.90 |
3 | F/63/L | HT | EMM | 20 | N/Fluid | NG | VC (1), CT (1) | Gatifloxacin | Y | None | 2.30 | 0.50 |
4 | M/71/L | HT, DLP | EMM | 23 | N/Fluid | Enterococcus faecium | VC (3), CT (3) | Ciprofloxacin | Y | None | 2.30 | 0.50 |
5 | F/63/R | HT | EMM | 23 | N/Fluid | NG | VC (1), CT (1) | Ciprofloxacin | N | None | 2.00 | 0.80 |
6 | F/69/L | Parkinson disease, Down syndrome | IOL dislocation | 23 | Y/fluid | NG | VC (1), CT (1) | - | Y | None | 2.30 | 0.70 |
7 | F/81/L | HT | IOL dislocation | 23 | Y/fluid | Proteus mirabilis | VC (2), CT (2) | - | Y | None | 2.60 | 2.90 |
8 | F/83/L | DM | Diabetic TRD | 23 | N/Air | Staphylococcus lugdunensis | VC (4), CT (1), CD (3) | Ciprofloxacin | Y | Elevated IOP | 2.60 | 2.30 |
9 | F/57/L | DM, HT | Diabetic TRD | 23 | Y/silicone oil | Aspergillus flavus | VC (1), CT (1) | Ciprofloxacin | N | Elevated IOP | 2.60 | 2.90 |
10 | F/68/R | None | EMM | 23 | N/Fluid | NG | VC (1), CT (1) | Ciprofloxacin | Y | RRD | 2.30 | 2.90 |
11 | M/56/L | None | Traumatic lens dislocation | 23 | Y/air | ND | VC (3), CT (3) | Ciprofloxacin | N | None | 2.00 | 2.90 |
12 | M/58/L | None | Traumatic lens dislocation | 25 | Y/air | NG | VC (3), CT (3) | Ciprofloxacin | N | None | 0.70 | 0.80 |
13 | M/78/R | None | Intra-operative lens dislocation | 25 | Y/air | NG | VC (3), CT (3) | Ciprofloxacin | Y | Elevated IOP | 2.30 | 0.50 |